| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated protein C modulates T-cell metabolism and epigenetic FOXP3 induction via α-ketoglutarate
|
Gupta, Dheerendra
|
|
|
7 |
17 |
p. 5055-5068
|
artikel
|
| 2 |
An NFIX-mediated regulatory network governs the balance of hematopoietic stem and progenitor cells during hematopoiesis
|
Walker, Megan
|
|
|
7 |
17 |
p. 4677-4689
|
artikel
|
| 3 |
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
|
Falter, Tanja
|
|
|
7 |
17 |
p. 5091-5102
|
artikel
|
| 4 |
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia
|
Chen, Li-Yun
|
|
|
7 |
17 |
p. 4913-4925
|
artikel
|
| 5 |
Anti-FVIII antibodies in Black and White hemophilia A subjects: do F8 haplotypes play a role?
|
Pratt, Kathleen P.
|
|
|
7 |
17 |
p. 4983-4998
|
artikel
|
| 6 |
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
|
Attardi, Enrico
|
|
|
7 |
17 |
p. 5122-5131
|
artikel
|
| 7 |
Assessment of HLA-DPB1 genetic variation using an HLA-DP tool and its implications in clinical transplantation
|
Sajulga, Ray
|
|
|
7 |
17 |
p. 4809-4821
|
artikel
|
| 8 |
BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5
|
Oien, Derek B.
|
|
|
7 |
17 |
p. 5108-5121
|
artikel
|
| 9 |
Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia
|
Li, Xiuqi
|
|
|
7 |
17 |
p. 5156-5171
|
artikel
|
| 10 |
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome
|
Bhaskar, Shakthi T.
|
|
|
7 |
17 |
p. 4765-4772
|
artikel
|
| 11 |
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
|
Buxbaum, Nataliya P.
|
|
|
7 |
17 |
p. 4886-4902
|
artikel
|
| 12 |
Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. Blood Adv. 2022;6(21):5716-5731.
|
|
|
|
7 |
17 |
p. 4999
|
artikel
|
| 13 |
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study
|
Kim, Won-Seog
|
|
|
7 |
17 |
p. 4903-4912
|
artikel
|
| 14 |
Detrimental effects of sickle cell disease and hydroxycarbamide on ovarian reserve but uncertain impact on fertility
|
Joseph, Laure
|
|
|
7 |
17 |
p. 4794-4798
|
artikel
|
| 15 |
Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia
|
Ujjani, Chaitra
|
|
|
7 |
17 |
p. 4728-4737
|
artikel
|
| 16 |
Editorial Board
|
|
|
|
7 |
17 |
p. i
|
artikel
|
| 17 |
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE
|
Wong, Raymond Siu Ming
|
|
|
7 |
17 |
p. 4773-4781
|
artikel
|
| 18 |
Flow cytometry as a fast, cost-effective tool to assess IGHV mutational status in CLL
|
Couillez, Guillaume
|
|
|
7 |
17 |
p. 4701-4704
|
artikel
|
| 19 |
Front Matter
|
|
|
|
7 |
17 |
p. ii
|
artikel
|
| 20 |
Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy
|
Garrett, Melanie E.
|
|
|
7 |
17 |
p. 4782-4793
|
artikel
|
| 21 |
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
|
Fenaux, Pierre
|
|
|
7 |
17 |
p. 5027-5037
|
artikel
|
| 22 |
Host metabolome predicts the severity and onset of acute toxicities induced by CAR T-cell therapy
|
Jalota, Akansha
|
|
|
7 |
17 |
p. 4690-4700
|
artikel
|
| 23 |
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia
|
Shahid, Sanam
|
|
|
7 |
17 |
p. 5069-5081
|
artikel
|
| 24 |
Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study
|
Epperla, Narendranath
|
|
|
7 |
17 |
p. 5038-5046
|
artikel
|
| 25 |
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
|
McCarter, Joseph G. W.
|
|
|
7 |
17 |
p. 5000-5013
|
artikel
|
| 26 |
Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis
|
Wang, YunZu Michele
|
|
|
7 |
17 |
p. 5137-5151
|
artikel
|
| 27 |
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
|
Merryman, Reid W.
|
|
|
7 |
17 |
p. 4748-4759
|
artikel
|
| 28 |
Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B
|
Schmidt, Manfred
|
|
|
7 |
17 |
p. 4966-4969
|
artikel
|
| 29 |
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
|
Bartlett, Nancy L.
|
|
|
7 |
17 |
p. 4926-4935
|
artikel
|
| 30 |
Natalizumab for GVHD: too little or too late?
|
Quann, Kevin
|
|
|
7 |
17 |
p. 5187-5188
|
artikel
|
| 31 |
No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study
|
Geerdes, Emma E.
|
|
|
7 |
17 |
p. 4869-4873
|
artikel
|
| 32 |
Novel risk assessment for the intensity of conditioning regimen in older patients
|
Akahoshi, Yu
|
|
|
7 |
17 |
p. 4738-4747
|
artikel
|
| 33 |
Patient-reported outcomes in children with sickle cell disease at presentation for an acute pain episode
|
Bakshi, Nitya
|
|
|
7 |
17 |
p. 5103-5107
|
artikel
|
| 34 |
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
|
Al Malki, Monzr M.
|
|
|
7 |
17 |
p. 5189-5198
|
artikel
|
| 35 |
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
|
Halpern, Anna B.
|
|
|
7 |
17 |
p. 4950-4961
|
artikel
|
| 36 |
Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon
|
Martyanov, Alexey A.
|
|
|
7 |
17 |
p. 4936-4949
|
artikel
|
| 37 |
Prevalence of frailty and its association with clinical outcomes in myeloproliferative neoplasms: a population-based study
|
Bankar, Aniket
|
|
|
7 |
17 |
p. 5014-5026
|
artikel
|
| 38 |
Proinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease
|
Zheng, Yan
|
|
|
7 |
17 |
p. 4799-4808
|
artikel
|
| 39 |
Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry
|
Mato, Anthony R.
|
|
|
7 |
17 |
p. 4760-4764
|
artikel
|
| 40 |
Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development
|
Dean, Sarai T.
|
|
|
7 |
17 |
p. 4822-4837
|
artikel
|
| 41 |
Retrospective characterization of nodal marginal zone lymphoma
|
Stuver, Robert
|
|
|
7 |
17 |
p. 4838-4847
|
artikel
|
| 42 |
Safe and efficient lentiviral vector integration with HSC-targeted gene therapy
|
Radtke, Stefan
|
|
|
7 |
17 |
p. 5132-5136
|
artikel
|
| 43 |
Secondary bile acids function through the vitamin D receptor in myeloid progenitors to promote myelopoiesis
|
Thompson, Brandon
|
|
|
7 |
17 |
p. 4970-4982
|
artikel
|
| 44 |
Splenectomy improves erythrocyte functionality in spherocytosis based on septin abundance, but not maturation defects
|
Cloos, Anne-Sophie
|
|
|
7 |
17 |
p. 4705-4720
|
artikel
|
| 45 |
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
|
Burack, W. Richard
|
|
|
7 |
17 |
p. 5082-5090
|
artikel
|
| 46 |
The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis
|
Hsu, Charles
|
|
|
7 |
17 |
p. 4721-4727
|
artikel
|
| 47 |
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
|
Hapgood, Greg
|
|
|
7 |
17 |
p. 5047-5054
|
artikel
|
| 48 |
The transcriptomic landscape of normal and ineffective erythropoiesis at single-cell resolution
|
Doty, Raymond T.
|
|
|
7 |
17 |
p. 4848-4868
|
artikel
|
| 49 |
The utility of biomarkers in acute GVHD prognostication
|
Spyrou, Nikolaos
|
|
|
7 |
17 |
p. 5152-5155
|
artikel
|
| 50 |
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
|
Johnson, William T.
|
|
|
7 |
17 |
p. 5172-5186
|
artikel
|
| 51 |
Treatment delays in children and young adults with lymphoma: a report from an East Africa lymphoma cohort study
|
Mawalla, William Frank
|
|
|
7 |
17 |
p. 4962-4965
|
artikel
|
| 52 |
YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia
|
Li, Huan
|
|
|
7 |
17 |
p. 4874-4885
|
artikel
|
Tijdschrift beschrijving